September price hold at SemaPen: time to decide with clinical support

Simon Edward • 30 August 2025

Ready to start your weight loss journey? Download the free SemaPen app and find out if you're eligible in minutes.

Get Started Free

September price hold at SemaPen: time to decide with clinical support

Mounjaro® pricing at SemaPen: September first month £159, then dose-based pricing

Many patients are weighing up next steps. To support calm, informed choices, we’re absorbing most of the Mounjaro® price rise through September for new and existing patients.


That means:


New starters: first month £159 with code WELCOME


From month two / existing patients:


  • 2.5 mg £199
  • 5 mg £225
  • 7.5 mg £249
  • 10 mg £275
  • 12.5 mg £289
  • 15 mg £299


This buys time to talk with our clinicians, adjust dose if appropriate, or consider Wegovy, which remains unchanged in price.

We expect to review pricing from 1 October 2025. Until then, our focus is continuity of care and helping you choose what suits you best.



Questions about your plan or next order?


Message us in the SemaPen app or call 01244 738 163.


The £159 first month applies to new patients who start in September and are clinically eligible.

  • Average 15–21% weight loss
  • Trusted programmes built by UK experts
  • Personalised advice and support
  • Smart weight loss app to track progress and learn positive habits

Your journey starts in the app

Unlock tailored support, weight tracking and more.

1

Download the free app

2

Take your digital consultation

3

Start your programme

Download the app
Doctors look at several things when prescribing Wegovy. Find out what questions you'll be asked
by Simon Edward 2 March 2026
Doctors look at several things when prescribing Wegovy. Find out what questions you'll be asked – and why.
Metabolic syndrome is a cluster of conditions that can lead to complications like type 2 diabetes.
by Simon Edward 27 February 2026
Metabolic syndrome is a cluster of conditions that can lead to complications like type 2 diabetes. Could Mounjaro help treat it? Let's find out.
Have you noticed itchiness when taking Wegovy (semaglutide)? Learn what's normal
by Simon Edward 23 February 2026
Have you noticed itchiness when taking Wegovy (semaglutide)? Learn what's normal and when to be concerned.
There's a strong link between obesity and hypertension (high blood pressure). But what causes it?
by Simon Edward 20 February 2026
There's a strong link between obesity and hypertension (high blood pressure). But what causes it? And what can you do to lower your risk?
Mounjaro can be a big helping hand for weight loss – but that doesn't mean you can eat anything
by Simon Edward 16 February 2026
Mounjaro can be a big helping hand for weight loss – but that doesn't mean you can eat anything and still lose weight. Learn what dieticians recommend.
Several new weight loss treatments are in development, including Amgen's MariTide. Get the key facts
by Simon Edward 13 February 2026
Several new weight loss treatments are in development, including Amgen's MariTide. Get the key facts about this US-made injectable medication.
Are you considering using Wegovy for weight loss? Read our beginner's guide
by Simon Edward 9 February 2026
Are you considering using Wegovy for weight loss? Read our beginner's guide to get the key information you need in one place.
Did you know that extreme calorie-cutting can make losing weight more difficult? Learn why –
by Simon Edward 6 February 2026
Did you know that extreme calorie-cutting can make losing weight more difficult? Learn why – and what to do instead.
Clinical trials have shown that Mounjaro is safe and effective as a treatment for obesity
by Simon Edward 2 February 2026
Clinical trials have shown that Mounjaro is safe and effective as a treatment for obesity and type 2 diabetes. Let's explore their findings in more detail.
Discover more about the FLOW study semaglutide trial, which looked at how Wegovy could lower risks
by Simon Edward 31 January 2026
Discover more about the FLOW study semaglutide trial, which looked at how Wegovy could lower risks in people with chronic kidney disease.
More posts